The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors

dc.contributorAalto-yliopistofi
dc.contributorAalto Universityen
dc.contributor.authorMinkkila, Annaen_US
dc.contributor.authorMyllymaki, Mikko J.en_US
dc.contributor.authorSaario, Susanna M.en_US
dc.contributor.authorCastillo-Melendez, Joel A.en_US
dc.contributor.authorKoskinen, Ari M.P.en_US
dc.contributor.authorFowler, Christopher J.en_US
dc.contributor.authorLeppanen, Jukkaen_US
dc.contributor.authorNevalainen, Tapioen_US
dc.contributor.departmentDepartment of Chemistryen
dc.date.accessioned2016-09-23T09:24:42Z
dc.date.issued2009en_US
dc.description.abstractA series of para-substituted phenolic N-alkyl carbamates were evaluated for their FAAH and MGL inhibitory activities. The compounds were generally selective for FAAH, with IC50 values in the nM range, whereas inhibition of MGL required concentrations three orders of magnitude higher. The most potent compounds, dodecylcarbamic acid 4-(4,5-dihydrothiazol-2-yl)phenyl (12) and 4-(1,2,3-thiadiazol-4-yl)phenyl (26) esters, inhibited FAAH and MGL with IC50 values at the low-nanomolar (IC50s; 0.0063 and 0.012 mM) and the low-micromolar ranges (IC50s; 2.1 and 1.0 mM), respectively. Compound 26 also inhibited both FAAH-dependent AEA uptake and AEA hydrolysis (IC50; 0.082 mM) by intact RBL2H3 cells, and could also reduce 2-AG hydrolysis by these cells at concentrations 0.030 mM.en
dc.description.versionPeer revieweden
dc.format.mimetypeapplication/pdfen_US
dc.identifier.citationMinkkila, A, Myllymaki, M J, Saario, S M, Castillo-Melendez, J A, Koskinen, A M P, Fowler, C J, Leppanen, J & Nevalainen, T 2009, 'The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors', European Journal of Medicinal Chemistry, vol. 44, no. 7, pp. 2994-3008. https://doi.org/10.1016/j.ejmech.2009.01.007en
dc.identifier.doi10.1016/j.ejmech.2009.01.007en_US
dc.identifier.issn0223-5234
dc.identifier.issn1768-3254
dc.identifier.otherPURE UUID: 7213b964-9680-450a-a28f-d9ddeeba6e7den_US
dc.identifier.otherPURE ITEMURL: https://research.aalto.fi/en/publications/7213b964-9680-450a-a28f-d9ddeeba6e7den_US
dc.identifier.otherPURE FILEURL: https://research.aalto.fi/files/7159754/ms140.pdfen_US
dc.identifier.urihttps://aaltodoc.aalto.fi/handle/123456789/22429
dc.identifier.urnURN:NBN:fi:aalto-201609234432
dc.language.isoenen
dc.publisherElsevier
dc.relation.ispartofseriesEuropean Journal of Medicinal Chemistryen
dc.relation.ispartofseriesVolume 44, issue 7, pp. 2994-3008en
dc.rightsopenAccessen
dc.subject.keywordendocannabinoiden_US
dc.subject.keywordN-Arachidonoylethanolamine (AEA)en_US
dc.subject.keyword2-Arachidonoylglycerol (2-AG)en_US
dc.subject.keywordfatty acid amide hydrolase (FAAH)en_US
dc.subject.keywordMonoglyceride lipaseen_US
dc.titleThe synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitorsen
dc.typeA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessäfi
dc.type.versionacceptedVersion

Files